Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Febrile Neutropenia × ceftolozane, tazobactam drug combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Classical hematology 1

Conditions

Hematologic Neoplasms 1 Febrile Neutropenia 1

Interventions

pegylated granulocyte colony-stimulating factor 3 pegfilgrastim 3 Vancomycin 3 Linezolid 2 Filgrastim 2 ceftolozane, tazobactam drug combination 1 Teicoplanin 1 Sodium Chloride 1 Piperacillin, Tazobactam Drug Combination 1 N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1 Meropenem 1 Itraconazole 1 Cefepime 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05061654 2023-08-14

CEF-10

Hamad Medical Corporation

Phase 4 Withdrawn

Classical hematologyOther hematologic neoplasm

Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡